Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF102.2.
  • Eventos
  • Noticias
  • Análisis
  • Cuenta
Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
  1. Inicio
  2. Noticias
  3. STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies

STAT News

STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies

After the failure of an experimental drug for Angelman syndrome, experts cautioned that there is still reason to think similar experimental medicines can succeed.

Continúe con el reportaje completo en el sitio web del editor.

Leer el artículo completo en STAT News
S

Por STAT News

4 September 2026|1 minuto de lectura
Compartir
Health Tech
STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies
STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies
Compartir
← Volver a IE News

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

  • STAT+: Fauci speaks, and writes

    STAT News

    STAT+: Fauci speaks, and writes

    3 September 2026
  • Disabled workers at greater risk of losing health insurance

    STAT News

    Disabled workers at greater risk of losing health insurance

    4 September 2026
  • STAT+: Seattle scientists launch $95 million AI biology effort

    STAT News

    STAT+: Seattle scientists launch $95 million AI biology effort

    3 September 2026
  • HHS flip-flops on disability lawsuit

    STAT News

    HHS flip-flops on disability lawsuit

    3 September 2026
  • STAT+: Abivax has still not been acquired. What’s going on?

    STAT News

    STAT+: Abivax has still not been acquired. What’s going on?

    3 September 2026
  • ‘Tactical athletes’ get new guidance for cardiovascular fitness

    STAT News

    ‘Tactical athletes’ get new guidance for cardiovascular fitness

    3 September 2026

Perspectivas relacionadas

  • Advanced manufacturing and industrial AI

    Rare Earth Elements: The Invisible Engine of Modern Life

    11 Aug 202610 min read
  • Smart agriculture and food technology

    The Future of Food: Vertical & Indoor Farming Is Becoming a Serious Growth Industry

    Vertical farming cuts water use 90%, grows food anywhere, anytime—and with costs plummeting, it’s both a climate lifeline and a trillion-dollar investment bet.

    2 Aug 202610 min read
  • Precision medicine and longevity

    AI Series: Predictive HealthCare

    Predictive and Preventive medicine is quietly rewiring how care works. Here's what's changing, what's real, and how to get ahead of it.

    28 Jul 202614 min read
Browse all insights →

Eventos relacionados

  • Project Finance & Project Financial Modelling - Oct 2026

    19 Oct 2025
  • ADIHEX 2026 (Abu Dhabi International Hunting and Equestrian Exhibition)

    28 Aug 2026
    Abu Dhabi, United Arab Emirates
  • Common S3nse - Conference + Hackathon

    4 Sept 2026
    Amsterdam, Netherlands
  • INFRAME Expo 2026

    4 Sept 2026
    India
Ver todos los eventos→

Más de la redacción

  • STAT+: FDA takes another look at botanical drugs

    STAT+: FDA takes another look at botanical drugs

    4 September 2026
  • STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more

    STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more

    4 September 2026
  • Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains

    Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains

    4 September 2026
  • Why are drug overdose deaths declining?

    Why are drug overdose deaths declining?

    3 September 2026
Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF102.2.